apropos continuous innovation don’t forget that 2RT is also presently being trialled re central serous retinopathy a market the coy values at US$60m per annum.
apropos continuous innovation don’t forget that 2RT is also...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $56.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $200.6K | 825.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 138341 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 62167 | 3 |
View Market Depth
| Last trade - 15.11pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
-0.010 ( 4.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 24.5¢ | 24.0¢ | 365287 | ||
| Last updated 15.11pm 30/05/2024 ? | |||||
| EYE (ASX) Chart |